NHS patient describes new eye cancer treatment as “best early Christmas present”
Wednesday, 4 December 2024 ()
The pioneering new drug was found to increase average overall survival by almost five months compared to other standard treatments - from 21.
The pioneering new drug was found to increase average overall survival by almost five months compared to other standard treatments - from 21.
|
||||
You Might Like |